Director, MEG Lead Neuroscience, Medical Evidence Generation

Bristol Myers Squibb • Princeton, NJ

1d • $207,490 - $251,433 • Hybrid

About The Position

The Director of Medical Evidence Generation in Medical Affairs will lead the strategy, development, and execution of robust evidence generation strategies for the Neuroscience portfolio. This involves utilizing Clinical Research Collaborations (CRCs), Medical Affairs Sponsored Studies (MASTs), and Investigator-Sponsored Research Studies (ISRs) to inform clinical development, support product value, and underpin medical strategy throughout the product lifecycle. This role requires a scientific and strategic leader who will collaborate across internal functions such as Medical Strategy, RWE/Epidemiology, Clinical Operations, Regulatory, HEOR, and Access & Value, as well as with external stakeholders including key opinion leaders (KOLs), academic partners, and data collaborators.

Requirements

• Advanced scientific degree (MD, PhD, PharmD, MS or the equivalent) required with extensive, relevant scientific, and/or strong clinical development experience.
• At least 5 years of experience in pharmaceutical clinical development, Medical Affairs, or relevant Commercial experience; previous customer-facing role experience highly desirable.
• Deep understanding of clinical research and evidence generation methodologies.
• Strong leadership presence and ability to influence in matrixed environments.
• Demonstrated ability to strategically analyze data generation opportunities with minimal supervision.
• Strategic thinker with strong execution discipline.
• Demonstrated ability to develop and sustain high-performing relationships with external thought leaders and internal matrix stakeholders.
• Adeptness at building credibility with external investigators and collaborative partners competently balancing business and scientific acumen complemented by strong leadership behaviors, authenticity, agility, and an enterprise mindset.
• Understanding of global healthcare systems and academic settings with a demonstrated ability to lead in ambiguous and changing healthcare/business environments.
• Exceptional communication and interpersonal skills to influence decision-making at all levels of the organization.
• Proven experience leading cross-functional study teams and governance interactions.
• Exceptional interpersonal and communication skills appropriately flexing based on audience; expertly leverages effective communication and negotiation skills to influence decisions.

Nice To Haves

• Previous customer-facing role experience highly desirable.

Responsibilities

• Define and drive the integrated evidence generation strategy (IEP) aligned with Medical Affairs and overall product strategy, spanning clinical trials (Phase II/IV), real-world evidence (RWE), non-interventional studies, registries, observational research, and health outcomes studies.
• Provide hands-on scientific leadership in the design of clinical studies including Phase II/IV trials, post-marketing commitment studies, Investigator-initiated and collaborative research as applicable.
• Lead or significantly contribute to protocol development as applicable, including Study design, Study objectives and endpoints, Eligibility criteria, Statistical considerations (in collaboration with Biostatistics), Operational feasibility.
• Be accountable for delivering CRCs, ISRs, and MASTs from concept ideation to governance approval and throughout the study lifecycle.
• Serve as a thought leader on evidence generation methodologies to ensure evidence plans are fit-for-purpose and impactful.
• Lead preparation and delivery of evidence generation proposals and updates including results to internal governance bodies and cross-functional stakeholders.
• Apply strong understanding of GCP, ICH guidelines, and clinical trial governance to ensure compliant and high-quality study execution.
• Partner with Clinical Operations and CROs to ensure studies are delivered on time, on budget, and with high data quality.
• Review and interpret clinical and real-world data to ensure medical relevance and scientific integrity.
• Engage with key opinion leaders (KOLs), academic investigators, and external research partners to co-develop high-impact evidence.
• Participate in advisory boards, steering committees, and scientific forums as necessary.
• Collaborate with cross-functional partners to ensure cohesive planning and execution of evidence generation activities across geographies and therapeutic areas.
• Oversee operational delivery of studies, ensuring scientific rigor, quality, compliance (GCP/SOP), timelines, and budgets.
• Act as a trusted internal advisor to global and regional Medical Affairs, Clinical Development, Access & Value, Regulatory, and Commercial teams on evidence gaps, opportunities, and study strategy.
• Contribute to scientific dissemination through publications, abstracts, congress presentations, and advisory boards.
• Contribute to the evolution of MEG therapeutic area strategy and value proposition.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees) Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays.
• Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
• All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

What This Job Offers

• Job Type: Full-time
• Career Level: Director